Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Vishakantha Murthy is active.

Publication


Featured researches published by Vishakantha Murthy.


Journal of Pharmacy and Pharmacology | 2013

Vildagliptin: an anti-diabetes agent ameliorates cognitive deficits and pathology observed in streptozotocin-induced Alzheimer's disease

Jayasankar Kosaraju; Vishakantha Murthy; Rizwan Basha Khatwal; Anil Dubala; Santhivardhan Chinni; Satish Kumar Muthureddy Nataraj; Duraiswamy Basavan

Adults who develop type 2 diabetes (T2D) at later stages are at a higher risk of developing Alzheimers disease (AD). Pharmacological agents such as dipeptidyl peptidase‐4 (DPP‐4) inhibitors that increase the levels of glucagon‐like peptide‐1 (GLP‐1) and ameliorate T2D have also become promising candidates as disease‐modifying agents in the treatment of AD. The present study investigates the efficacy of vildagliptin, a DPP‐4 inhibitor in a streptozotocin (STZ)‐induced rat model of AD.


Indian Journal of Anaesthesia | 2014

Post-operative cognitive dysfunction in the elderly: A prospective clinical study

Nalini Kotekar; Caroline Sheryl Kuruvilla; Vishakantha Murthy

Background and Aims: Aging population is a major demographic trend worldwide. Globally, 50% of all the elderly individuals are estimated to undergo atleast one surgical procedure and post-operative cognitive dysfunction (POCD) is one of the most common and often poorly understood post-operative complications in this section of the population. This randomised prospective study was conducted to assess the post-operative cognitive status in the elderly undergoing non-cardiac surgery, evaluate the cognitive parameters affected, evaluate the potential risk factors and thereby analyse the potential for implementation of preventive strategies. Methods: This study was conducted on 200 patients aged 60 years or older scheduled for elective non-cardiac surgeries. The baseline cognitive status of the patients was assessed 2 days prior to the date of the surgery. The post-operative cognitive status was assessed on the 3 rd day, 7 th day and after 1 month. Statistical analysis was performed using SAS and SPSS. Results: The incidence of POCD showed a gradual decline from postoperative day 3 to 30. Females were found to be at significant risk in developing POCD. Advancing age and level of education emerged as dominant factors, while type of anaesthesia, duration of surgery, and presence of coexisting comorbidities had no influence on the incidence of cognitive dysfunction. Conclusion: POCD is a definite complication after surgery and anaesthesia in the elderly population. Gender emerged as a significant risk factor with increasing age as a dominating factor contributing to POCD.


Pulmonary Pharmacology & Therapeutics | 2014

5-Aminosalicylic acid attenuates allergen-induced airway inflammation and oxidative stress in asthma.

K. Rama Satyanarayana Raju; M.N. Sathish Kumar; Saurabh Gupta; Srinivas T. Naga; Jaya K. Shankar; Vishakantha Murthy; Subba Rao V. Madhunapanthula; Shashank Mulukutla; Nilesh S. Ambhore; Shashank Tummala; V.J. Vishnuvarthan; Afzal Azam; K. Elango

Pro-inflammatory cytokines regulate the magnitude of allergic reactions during asthma. Tumor necrosis factor--alpha (TNF-α), interleukin-6 (IL-6) and interleukin-13 (IL-13) play a crucial role in aggravating the inflammatory conditions during allergic asthma. In addition, oxidative stress contributes to the pathogenesis of asthma by altering the physiological condition resulting in the development of status asthmaticus. Anti-inflammatory corticosteroids are being widely used for treating allergic asthma. In the present study 5-aminosalicylic acid (5-ASA), a salicylic acid derivative, was evaluated, in vivo for its potential to suppress TNF-α, IL-6 and IL-13 using ovalbumin (OVA) induced allergic asthma in Balb/C mice. Oral administration of 65, 130 and 195 mg/kg 5-ASA significantly reduced the OVA induced total and differential leucocyte count, TNF-α, IL-6, IL-13, nitrite, nitrate, MDA, MPO and TPL levels in the lung lavage samples. Collectively, these findings suggest that 5-ASA is a potent immunomodulator and suppresses key Th2 cytokines production and oxidative stress in OVA-induced asthma.


Journal of Pharmacology and Experimental Therapeutics | 2016

Cocaine Hydrolase Gene Transfer Demonstrates Cardiac Safety and Efficacy against Cocaine-Induced QT Prolongation in Mice

Vishakantha Murthy; Santiago Reyes; Liyi Geng; Yang Gao; Stephen Brimijoin

Cocaine addiction is associated with devastating medical consequences, including cardiotoxicity and risk-conferring prolongation of the QT interval. Viral gene transfer of cocaine hydrolase engineered from butyrylcholinesterase offers therapeutic promise for treatment-seeking drug users. Although previous preclinical studies have demonstrated benefits of this strategy without signs of toxicity, the specific cardiac safety and efficacy of engineered butyrylcholinesterase viral delivery remains unknown. Here, telemetric recording of electrocardiograms from awake, unrestrained mice receiving a course of moderately large cocaine doses (30 mg/kg, twice daily for 3 weeks) revealed protection against a 2-fold prolongation of the QT interval conferred by pretreatment with cocaine hydrolase vector. By itself, this prophylactic treatment did not affect QT interval duration or cardiac structure, demonstrating that viral delivery of cocaine hydrolase has no intrinsic cardiac toxicity and, on the contrary, actively protects against cocaine-induced QT prolongation.


Medical Hypotheses | 2016

Salicylic acid derivatives as potential anti asthmatic agents using disease responsive drug delivery system for prophylactic therapy of allergic asthma

Kalidhindi Rama Satyanarayana Raju; Nilesh S. Ambhore; Shashank Mulukutla; Saurabh Gupta; Vishakantha Murthy; M.N. Kiran Kumar; Subba Rao V. Madhunapantula; Gowthamarajan Kuppuswamy; K. Elango

Asthma is a multi-factorial and complicated lung disorder of the immune system which has expanded to a wider ambit unveiling its etiology to be omnipresent at both ends of the spectrum involving basic pharmacology and in-depth immunology. As asthma occurs through triggered activation of various immune cells due to different stimuli, it poses a great challenge to uncover specific targets for therapeutic interventions. Recent pharmacotherapeutic approaches for asthma have been focused on molecular targeting of transcription factors and their signaling pathways; mainly nucleus factor kappa B (NFκB) and its associated pathways which orchestrate the synthesis of pro-inflammatory cytokines (IL-1β, TNF-α, GM-CSF), chemokines (RANTES, MIP-1a, eotaxin), adhesion molecules (ICAM-1, VCAM-1) and inflammatory enzymes (cyclooxygenase-2 and iNOS). 5-aminosalicylic acid (5-ASA) and sodium salicylate are known to suppress NFκB activation by inhibiting inhibitor of kappa B kinase (IKκB). In order to target the transcription factor, a suitable carrier system for delivering the drug to the intracellular space is essential. 5-ASA and sodium salicylate loaded liposomes incorporated into PEG-4-acrylate and CCRGGC microgels (a polymer formed by crosslinking of trypsin sensitive peptide and PEG-4-acrylate) could probably suit the needs for developing a disease responsive drug delivery system which will serve as a prophylactic therapy for asthmatic patients.


Journal of Pharmaceutical and Biomedical Analysis | 2016

Pharmacokinetic and tissue distribution studies of 1,9-pyrazoloanthrone, a c-Jun-N-terminal kinase inhibitor in Wistar rats by a simple and sensitive HPLC method

Nilesh S. Ambhore; Karthik Yamjala; Shubhashri Mohire; Kalidhindi Rama Satyanarayana Raju; Shashank Mulukutla; Vishakantha Murthy; Mahesh Tondhawada; K. Elango

JNK pathway activates c-Jun(s) which are responsible for cell apoptosis; as a result, inhibitors of JNK pathway have the potential to prevent dopaminergic neurons from death and decrease the loss of dopamine in substantia nigra pars compacta (SNpc). Recent in-vitro studies show that 1,9-pyrazoloanthrone (1,9-P) a potent JNK-3 inhibitor prevents the apoptosis of dopaminergic cells of brain. In the present study we formulated liposomes to increase the bioavailability of 1,9-P in the brain and developed a simple, sensitive and selective high performance liquid chromatographic method and validated for the estimation of 1,9-P in Wistar rat plasma and tissue samples. Plasma and tissue samples were extracted by protein precipitation technique using acetonitrile (ACN) and rasagiline as the internal standards. Chromatography was performed on Hibar C18 column with mobile phase of ammonium acetate (10mM, pH 8.0 adjusted with ammonia) and ACN at a flow rate of 1mL/min. The lower limit of quantification of the developed method was found to be 2.0ng/mL and 4.0ng/g in plasma and tissue samples respectively. The liposomes of 1,9-P administered to animals at the dose equivalent to 15mg/kg orally demonstrated remarkable absorption into the systemic circulation with maximum concentration (∼7500ng/mL) within 2.0h. The order of the area under curve was found to be kidney>liver>brain>lungs>spleen>heart. The liposomes of 1,9-P were rapidly taken up into brain and showed a good brain concentration after 2.0h; sustenance up to 4.0h was achieved which is better than 1,9-P solution.


Journal of Molecular Neuroscience | 2014

Preclinical Studies on Neurobehavioral and Neuromuscular Effects of Cocaine Hydrolase Gene Therapy in Mice

Vishakantha Murthy; Yang Gao; Liyi Geng; Nathan K. LeBrasseur; Thomas A. White; Stephen Brimijoin


Vaccine | 2014

Physiologic and metabolic safety of butyrylcholinesterase gene therapy in mice

Vishakantha Murthy; Yang Gao; Liyi Geng; Nathan K. LeBrasseur; Thomas A. White; Robin J. Parks; Stephen Brimijoin


Cellular and Molecular Neurobiology | 2015

Reward and Toxicity of Cocaine Metabolites Generated by Cocaine Hydrolase

Vishakantha Murthy; Liyi Geng; Yang Gao; Bin Zhang; Jordan D. Miller; Santiago Reyes; Stephen Brimijoin


Der Pharma Chemica | 2018

5-Amino Salicylic Acid and Sodium Salicylate Inhibit Activation of Iandkappa;B Kinase and P38 andgamma; MAP Kinase in LPS Induced RAW 264.7 cell

Rama Satyanarayana Raju Kalidhindi; Saurabh Gupta; Gurjeet Thakur; eep Arora; Nilesh Sudhakar Ambhore; Vishakantha Murthy; Ashish D Wadhwani; Md. Afzal Azam; K. Elango

Collaboration


Dive into the Vishakantha Murthy's collaboration.

Top Co-Authors

Avatar

K. Elango

Jagadguru Sri Shivarathreeswara University

View shared research outputs
Top Co-Authors

Avatar

Nilesh S. Ambhore

Jagadguru Sri Shivarathreeswara University

View shared research outputs
Top Co-Authors

Avatar

Shashank Mulukutla

Jagadguru Sri Shivarathreeswara University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Saurabh Gupta

Oak Ridge National Laboratory

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Shubhashri Mohire

Jagadguru Sri Shivarathreeswara University

View shared research outputs
Top Co-Authors

Avatar

Elango Kannan

Jagadguru Sri Shivarathreeswara University

View shared research outputs
Top Co-Authors

Avatar

Kalidhindi Rama Satyanarayana Raju

Jagadguru Sri Shivarathreeswara University

View shared research outputs
Researchain Logo
Decentralizing Knowledge